Page 2 - Monarch Platform News Today

Study will advance the validation of Cellvizio as a real-time biopsy guidance tool during robotic-assisted bronchoscopy that may reduce the near-miss rate of peripheral lung cancer Regulatory News:

Hollywood, Fla (PRWEB) February 04, 2022 -- More than 90 percent of people diagnosed with lung cancer do not survive the disease, usually because it is

A select rundown of stories found on InForum.

The Monarch Platform, a robotic endoscope, helps physicians locate and diagnose cancerous nodules in the lungs more easily than was possible before. The technology is the first to operate in the region.

The Monarch Platform, a robotic endoscope, helps physicians locate and diagnose cancerous nodules in the lungs more easily than was possible before. The technology is the first to operate in the region.

The Monarch Platform, a robotic endoscope, helps physicians locate and diagnose cancerous nodules in the lungs more easily than was possible before. The technology is the first to operate in the region.

The Monarch Platform, a robotic endoscope, helps physicians locate and diagnose cancerous nodules in the lungs more easily than was possible before. The technology is the first to operate in the region.

The Monarch Platform, a robotic endoscope, helps physicians locate and diagnose cancerous nodules in the lungs more easily than was possible before. The technology is the first to operate in the region.

The Monarch Platform, a robotic endoscope, helps physicians locate and diagnose cancerous nodules in the lungs more easily than was possible before. The technology is the first to operate in the region.

The Monarch Platform, a robotic endoscope, helps physicians locate and diagnose cancerous nodules in the lungs more easily than was possible before. The technology is the first to operate in the region.